In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles

Erik Rytting, Michael Bur, Regis Cartier, Thierry Bouyssou, Xiaoying Wang, Michael Krüger, Claus Michael Lehr, Thomas Kissel

Research output: Contribution to journalArticle

46 Scopus citations

Abstract

The development and performance of a novel nanoparticle-based formulation for pulmonary delivery has been characterized chronologically through the particle preparation process, in vitro testing of drug release, biocompatibility, degradation, drug transport in cell culture, and in vivo bronchoprotection studies in anaesthetised guinea pigs. This study demonstrates excellent agreement of the in vitro and in vivo experiments undertaken to prove the feasibility of the design, thereby serving as an example highlighting the importance of in vitro test methods that predict in vivo performance. Nanoparticles were prepared from the newly designed negatively-charged polymer poly(vinyl sulfonate-co-vinyl alcohol)-g-poly(d,l-lactic-co-glycolic acid) loaded with salbutamol free base. Average particle sizes of blank and drug-loaded nanoparticles prepared at the various stages of the investigations were between 91 and 204 nm; average zeta potential values were between - 50.1 and - 25.6 mV. Blank nanoparticles showed no significant toxicity, and no inflammatory activity was detected in Calu-3 cells. Sustained release of salbutamol from the nanoparticles was observed for 2.5 h in vitro, and a prolonged effect was observed for 120 min in vivo. These results demonstrate good agreement between in vitro and in vivo tests and also present a promising foundation for future advancement in nanomedicine strategies for pulmonary drug delivery.

Original languageEnglish (US)
Pages (from-to)101-107
Number of pages7
JournalJournal of Controlled Release
Volume141
Issue number1
DOIs
StatePublished - Jan 4 2010
Externally publishedYes

Keywords

  • Biocompatibility
  • In vitro-in vivo correlation
  • Nanoparticle
  • Pulmonary drug delivery
  • Salbutamol

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles'. Together they form a unique fingerprint.

  • Cite this